{
    "code": "01007544",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01007544",
    "time": "2023-10-13 15:41:12",
    "許可證字號": "衛署藥製字第007544號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/09\/26",
    "發證\/登錄日期": "64\/09\/26",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00100754402",
    "中文品名": "鹽酸氯普魯麻淨注射劑１２５公絲\/５公撮",
    "英文品名": "CHLORPROMAZINE HCL 125MG\/5ML &quot;VPP&quot;",
    "適應症": "躁病、噁心、嘔吐、精神病狀態、攻擊性與破壞性之行為障礙",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CHLORPROMAZINE HCL",
    "限制項目": "01國　產 1R不得製造",
    "申請商名稱": "榮民製藥股份有限公司",
    "申請商地址": "桃園市中壢區中山東路３段４４７號",
    "主製造廠": [
        {
            "製造廠名稱": "信東生技股份有限公司",
            "製造廠廠址": "桃園市桃園區介壽路22號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816900310",
            "成分名稱": "CHLORPROMAZINE HCL",
            "含量描述": "125",
            "含量": "125.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "007544 鹽酸氯普魯麻淨注射劑125公絲-公撮仿單依公告變更-103-11-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01007544&Seq=002&Type=9"
        }
    ]
}